Showing results (171-180 of 233) with videos related to
Sort By:
Pageof 24
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2008
Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticlesWuping Li, Aravind Asokan, Zhijian Wu, et al.JCI Insight|October 14, 2016
Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysisWenjin Liu, Jeff M Snell, William R Jeck, et al.Journal of AOAC International|October 7, 2010
Preparation and characterization of standard reference material 1849 infant/adult nutritional formulaKatherine E Sharpless, Richard M Lindstrom, Bryant C Nelson, et al.Plos One|April 3, 2009
Somatic LKB1 mutations promote cervical cancer progressionShana N Wingo, Teresa D Gallardo, Esra A Akbay, et al.Antiviral Therapy|January 6, 2016
Tenofovir/emtricitabine metabolites and endogenous nucleotide exposures are associated with p16(INK4a) expression in subjects on combination therapyJulie B Dumond, Owen Francis, Mackenzie Cottrell, et al.Nature Medicine|December 15, 2015
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in miceJianhui Chang, Yingying Wang, Lijian Shao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer modelsPatrick J Roberts, Jerry E Usary, David B Darr, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Predicting drug responsiveness in human cancers using genetically engineered miceJerry Usary, Wei Zhao, David Darr, et al.Analytical Chemistry|December 7, 2011
Development and certification of a standard reference material for vitamin D metabolites in human serumKaren W Phinney, Mary Bedner, Susan S-C Tai, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2013
Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistanceZhao Chen, Esra Akbay, Oliver Mikse, et al.Pageof 24